Market Tracker

10/30 6:17pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

5.49
Data as of 2:38pm ET
 +0.21 / +3.98%
Today’s Change
4.28
Today|||52-Week Range
19.11
-32.05%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close5.28
Today’s open5.29
Day’s range5.14 - 5.49
Volume52,689
Average volume (3 months)382,916
Market cap$116.2M
Dividend yield--
Data as of 2:38pm ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-33.10%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book108.60

Competitors

 Today’s
change
Today’s
% change
ERBERBA Diagnostics Inc-0.02-0.63%
QTNTQuotient Ltd-0.03-0.30%
TROVTrovagene Inc+0.72+16.40%
LPDXLipoScience Inc+0.01+0.19%
Data as of 2:52pm ET, 10/30/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts